Skip to content
CompletedPhase 1Results posted

Effect of Stimulant Drugs on Social Perception

NCT03790618 · ESP · University of Chicago

Closed to entry
Status
Not accepting participants
Phase 1
Phase
36
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

The study will improve our understanding of the "prosocial" effects of ± 3,4-Methylenedioxymethamphetamine (MDMA), relative to a prototypical stimulant, methamphetamine (MA). The investigators seek to characterize the "uniquely social" effects of MDMA.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Responses to Affective Touch

    Measured over End of study (time 0 and approximately six weeks later)

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 35 Years
Ages
All
Sex
Accepted
Healthy volunteers
Inclusion Criteria: * High school degree * English fluency * Healthy * Has used MDMA Exclusion Criteria: * Pregnant or trying to become pregnant * Any medical or psychiatry condition

Where

1 study site

FacilityCityRegionCountry
University of ChicagoChicagoIllinoisUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT03790618 on ClinicalTrials.gov →

Last updated in the registry 2024-01-05. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits